DSM-Firmenich AG Updates Share Repurchase Program

DSM-Firmenich AG, a leading innovator in nutrition, health, and beauty products, has made significant progress in its share repurchase program. The company aims to repurchase ordinary shares with an aggregate market value of CHF 500 million, reducing its issued capital in the process.

This move is expected to cover share plans and minimize capital. The share repurchase program is in line with the company’s strategy to optimize its capital structure and return value to shareholders.

Industry Recognition and Innovation

DSM-Firmenich has been recognized as a global industry giant, competing alongside other prominent companies such as Ashland and Eastman. The company’s innovative ingredient, KT-939 developed by Kintor, has been selected for the 2025 NYSCC Inspiration Hive Zone, marking a significant achievement for the Chinese ingredient in a highly competitive global market.

Key Highlights

• DSM-Firmenich aims to repurchase ordinary shares with an aggregate market value of CHF 500 million
• The share repurchase program is expected to cover share plans and minimize capital
• The company’s KT-939 ingredient has been selected for the 2025 NYSCC Inspiration Hive Zone